Differential expression and effects of gp130 cytokines and receptors in prostate cancer cells

Int J Biochem Cell Biol. 2004 Nov;36(11):2258-69. doi: 10.1016/j.biocel.2004.04.017.


High levels of circulating interleukin-6 (IL6), and possibly neuroendocrine (NE) differentiation, correlate with advanced prostate cancer (PCa). IL6 has many overlapping biological effects with the related gp130 cytokines LIF and OSM that can be explained by the shared usage of the signalling receptor, gp130. We set out to determine whether LIF and OSM can substitute for IL6 in PCa, particularly in relation to neuroendocrine differentiation. Expression analysis of the gp130 cytokines and receptors by RT-PCR, Southern blotting and immunohistochemistry showed that they are widely expressed in LNCaP, DU145 and PC3 cells, but not in normal prostate epithelial PZ-HPV-7 cells. IL6, but not LIF or OSM inhibited proliferation, induced NE differentiation and tyrosine phosphorylation of STAT3 in LNCaP cells. The data suggests that IL6 has a unique role in the progression of PCa.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / metabolism*
  • Cell Differentiation / physiology*
  • Cell Proliferation
  • Cytokine Receptor gp130
  • Cytokines / metabolism*
  • DNA-Binding Proteins
  • Humans
  • Interleukin-6 / metabolism*
  • Leukemia Inhibitory Factor
  • Male
  • Membrane Glycoproteins / metabolism*
  • Microscopy, Electron, Transmission
  • Phosphorylation
  • Prostatic Neoplasms / metabolism*
  • Proteins / metabolism
  • STAT3 Transcription Factor
  • Signal Transduction / physiology
  • Trans-Activators
  • Tumor Cells, Cultured


  • Antigens, CD
  • Cytokines
  • DNA-Binding Proteins
  • IL6ST protein, human
  • Interleukin-6
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • Membrane Glycoproteins
  • Proteins
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Trans-Activators
  • Cytokine Receptor gp130